SUNNYVALE, Calif., Sept. 9, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS) a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to neurodegeneration and apoptosis, today announced that it’s President & CEO Gerald Commissiong will make a corporate presentation at the 15th Annual Rodman & Renshaw Global Investor Conference in New York City on September 10th, 2013, sponsored by H.C. Wainwright & Co., LLC.
Help employers find you! Check out all the jobs and post your resume.
